SCHEMBL29845366

SCHEMBL29845366

O=[N+]([O-])c1ccc(Cl)c2c(NS(=O)(=O)C3CC3)nn(CC(F)F)c12

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.33
TXNRD1 Q16881 2/20 0.33
GSR P00390 1/20 0.33
MAPT P10636 1/20 0.31
EPHX2 P34913 1/20 0.30
VCAM1 P19320 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21811250 1.00 SCN9A (0.33) SCN9ATXNRD1GSRMAPTEPHX2
SCHEMBL21811211 0.85 VCAM1 (0.34) MAPTVCAM1
SCHEMBL20552538 0.84 SCN9A (0.35) SCN9A
SCHEMBL24142758 0.83 SCN9A (0.35) SCN9A
SCHEMBL23205965 0.83
SCHEMBL24997654 0.81 SCN9A (0.35) SCN9AEPHX2
SCHEMBL22681277 0.79 TDP1 (0.31) MAPTVCAM1
SCHEMBL21811248 0.77 TDP1 (0.36) MAPTVCAM1
SCHEMBL29845354 0.77 TDP1 (0.36) MAPTVCAM1
SCHEMBL30774090 0.77 CCR4 (0.37) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041729-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2022-08-17 EP disclosed
EP-4038064-A1 N-SUBSTUTUTED-6-OXO-1,6-DIHYDROPYRIMIDINE-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2022-08-10 EP disclosed